🇺🇸 Advair 250 in United States

54 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 54

Most-reported reactions

1. Fatigue — 7 reports (12.96%)
2. Nausea — 7 reports (12.96%)
3. Dyspnoea — 6 reports (11.11%)
4. Influenza — 6 reports (11.11%)
5. Pneumonia — 6 reports (11.11%)
6. Insomnia — 5 reports (9.26%)
7. Vomiting — 5 reports (9.26%)
8. Diarrhoea — 4 reports (7.41%)
9. Hyperhidrosis — 4 reports (7.41%)
10. Muscle Spasms — 4 reports (7.41%)

Source database →

Frequently asked questions

Is Advair 250 approved in United States?

Advair 250 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Advair 250 in United States?

Milton S. Hershey Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.